The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells

Cancer Research

Volumn 61, Issue 20, 2001, Pages 7488-7494

  Lavigne, Jackie A ^a   Goodman, Julie E ^a   Fonong, Tekum ^a   Odwin, Shelly ^a   He, Ping ^a   Yager, James D ^a   Roberts, Dean W ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b National Center for Toxicological Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' FLUORO 3,4 DIHYDROXY 5 NITROBENZOPHENONE; 8 HYDROXYDEOXYGUANOSINE; CATECHOL METHYLTRANSFERASE; DIOXIN; ESTRADIOL;

ARTICLE; BREAST CANCER; CANCER RISK; CELL STRAIN MCF 7; CONTROLLED STUDY; CULTURE MEDIUM; DNA DAMAGE; DNA POLYMORPHISM; ELECTROCHEMISTRY; ENZYME ACTIVITY; ESTROGEN METABOLISM; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; METHYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR;

BENZOPHENONES; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; DEOXYGUANOSINE; DNA DAMAGE; DNA, NEOPLASM; ENZYME INHIBITORS; ESTRADIOL; ESTROGENS, CATECHOL; HUMANS; OXIDATIVE STRESS; TUMOR CELLS, CULTURED;

EID: 0035887450     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Estrogens and breast cancer
2. Endogenous estrogens as carcinogens through metabolic activation
3. Hormone-associated cancer: Mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters
4. Molecular mechanisms of estrogen carcinogenesis
5. Functional role of estrogen metabolism in target cells: Review and perspectives
6. Medical hypothesis: Bifunctional genetic-hormonal pathways to breast cancer
7. Induction of uterine adenocarcinomas in CD-1 mice by catechol estrogens
8. Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: Studies using Syrian hamster embryo cells treated with 17β-estradiol and eight of its metabolites
9. Molecular characteristics of catechol estrogen quinones in reactions of deoxyribonucleosides
10. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
11. Estrogens as endogenous genotoxic agents-DNA adducts and mutations
12. Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: Potential biomarkers for estrogen-initiated cancer
13. Free radical generation by redox cycling of estrogens
14. DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol
15. 2+
16. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: Role of free radicals in estrogen-induced carcinogenesis
17. Measurement of oxidative DNA damage by catechol estrogens and analogues in vitro
18. Major alterations in the nucleotide structure of DNA in cancer of the female breast
19. The etiology of breast cancer. Characteristic alterations in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk
20. Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes
21. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis
22. Artifacts associated with the measurement of oxidized DNA bases
23. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers
24. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
25. Catecholestrogens are MCF-7 cell agonists
26. 4-Hydroxylation of estrogens as marker of human mammary tumors
27. Tissue-specific synthesis and oxidative metabolism of estrogens
28. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1: A comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA
29. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: Evidence for induction of a novel 17β-estradiol 4-hydroxylase
30. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1
31. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells
32. Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log differences in activity toward parallel substrates including hyodeoxycholic acid and certain estrogen derivatives
33. Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7
34. Catechol-O-methyl transferase: Pharmacological aspects and physiological role
35. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues
36. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines
37. Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters
38. Inhibition of the catechol-O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by catecholamine: Implications for the mechanism of estrogen-induced carcinogenesis
39. Kinetics of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation
40. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth
41. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: Possible role for stress-activated protein kinase signaling pathway and Fas expression
42. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
43. The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumors
44. Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic. Arrest, apoptosis, and microtubule assembly in human breast cancer cells
45. Catechol-O-methyltransferase, thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity
46. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders
47. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles
48. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer
49. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk
50. Catechol-O-methyltransferase and breast cancer risk
51. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility
52. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer
53. Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase
54. 2,3,7,8-Tetrachloro-p-dioxin causes an extensive alteration of 17β-estradiol metabolism in MCF-7 breast tumor cells
55. New selective COMT inhibitors: Useful adjuncts for Parkinson's disease?
56. Determination of catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection
57. Assays of oxidative DNA damage biomarkers 8-oxo-2′-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection
58. Analysis of phytoestrogens and polyphenols in plasma, tissue, and urine using HPLC with coulometric array detection